TKI258 (CHIR-258) selectively inhibits FGFR1 fusion genes associated with the 8p11 myeloproliferative syndrome.

被引：0
|
作者：
Chase, Andrew [1 ]
Grand, Francis H. [1 ]
Cross, Nicholas C. P. [1 ]
机构：
[1] Univ Southampton, Wessex Reg Genet Lab, Salisbury, Wilts, England
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
10.1182/blood.V108.11.2699.2699
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2699
引用
收藏
页码：763A / 763A
页数：1
相关论文
共 37 条
  • [21] Quantitative polymerase chain reaction detection of CEP110-FGFR1 fusion gene in a patient with 8p11 myeloproliferative syndrome
    Yamamoto, Shohei
    Ebihara, Yasuhiro
    Mochizuki, Shinji
    Kawakita, Toshiro
    Kato, Seiko
    Ooi, Jun
    Takahashi, Satoshi
    Tojo, Arinobu
    Yusa, Nozomi
    Furukawa, Yoichi
    Oyaizu, Naoki
    Watanabe, Junichi
    Sato, Ken
    Kimura, Fumihiko
    Tsuji, Kohichiro
    LEUKEMIA & LYMPHOMA, 2013, 54 (09) : 2068 - 2069
  • [22] The kinase inhibitor TKI258 is active against the novel CUX1-FGFR1 fusion detected in a patient with T-lymphoblastic leukemia/lymphoma and t(7;8)(q22;p11)
    Wasag, Bartosz
    Lierman, Els
    Meeus, Peter
    Cools, Jan
    Vandenberghe, Peter
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (06): : 922 - 926
  • [23] The Kinase Inhibitor TKI258 Is Active Against the Novel CUX1-FGFR1 Fusion Detected In a Patient with T-Lymphoblastic Leukemia/Lymphoma and t(7;8)(q22;p11)
    Wasag, Bartosz
    Lierman, Els
    Meeus, Peter
    Cools, Jan
    Vandenberghe, Peter
    BLOOD, 2010, 116 (21) : 1119 - 1119
  • [24] Distinct stem cell myeloproliferative/T lymphoma syndromes induced by ZNF198-FGFR1 and BCR-FGFR1 fusion genes from 8p11 translocations
    Roumiantsev, S
    Krause, DS
    Neumann, CA
    Dimitri, CA
    Asiedu, F
    Cross, NCP
    Van Etten, RA
    CANCER CELL, 2004, 5 (03) : 287 - 298
  • [25] Primary cells in BCR/FGFR1-positive 8p11 myeloproliferative syndrome are sensitive to dovitinib, ponatinib, and dasatinib
    Landberg, Niklas
    Dreimane, Arta
    Rissler, Marianne
    Billstrom, Rolf
    Agerstam, Helena
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2017, 99 (05) : 442 - 448
  • [26] B-cell acute lymphoblastic leukemia as evolution of a 8p11 myeloproliferative syndrome with t(8;22)(p11;q11) and BCR-FGFR1 fusion gene
    Baldazzi, Carmen
    Iacobucci, Ilaria
    Luatti, Simona
    Ottaviani, Emanuela
    Marzocchi, Giulia
    Paolini, Stefania
    Stacchini, Monica
    Papayannidis, Cristina
    Gamberini, Carla
    Martinelli, Giovanni
    Baccarani, Michele
    Testoni, Nicoletta
    LEUKEMIA RESEARCH, 2010, 34 (10) : E282 - E285
  • [27] A novel t(1;8)(q25;p11.2) translocation associated with 8p11 myeloproliferative syndrome
    Yoshida, Chikamasa
    Takeuchi, Makoto
    Sadahira, Yoshito
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 156 (02) : 271 - 273
  • [28] Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder.
    Fioretos, T
    Panagopoulos, I
    Lassen, C
    Swedin, A
    Billstrom, R
    Isaksson, M
    Strombeck, B
    Olofsson, T
    Mitelman, F
    Johansson, B
    BLOOD, 2001, 98 (11) : 558A - 558A
  • [29] Diagnostic application of next-generation sequencing in ZMYM2-FGFR1 8p11 myeloproliferative syndrome: A case report
    Wang, Yadan
    Wu, Xiaofei
    Deng, Jun
    Yu, Hao
    Xu, Ren
    Zhu, Zhiyi
    Tu, Shichun
    Hu, Yu
    CANCER BIOLOGY & THERAPY, 2016, 17 (08) : 785 - 789
  • [30] A Case of 8p11 Myeloproliferative Syndrome with BCR-FGFR1 Gene Fusion Presenting with Trilineage Acute Leukemia/Lymphoma, Successfully Treated by Cord Blood Transplantation
    Morishige, Satoshi
    Oku, Eijiro
    Takata, Yuka
    Kimura, Yoshizo
    Arakawa, Fumiko
    Seki, Ritsuko
    Imamura, Rie
    Osaki, Koichi
    Hashiguchi, Michitoshi
    Yakushiji, Kazuaki
    Mizuno, Shinichi
    Yoshimoto, Koji
    Nagafuji, Koji
    Ohshima, Koichi
    Okamura, Takashi
    ACTA HAEMATOLOGICA, 2013, 129 (02) : 83 - 89
1234